Shureiqi I - Search Results

1

Expression of 12-lipoxygenase as a biomarker for melanoma carcinogenesis.

Winer I, Normolle DP, Shureiqi I, Sondak VK, Johnson T, Su L, Brenner DE. Winer I, et al. Among authors: shureiqi i. Melanoma Res. 2002 Oct;12(5):429-34. doi: 10.1097/00008390-200209000-00003. Melanoma Res. 2002. PMID: 12394183

2

Chemoprevention of epithelial cancers.

Shureiqi I, Brenner DE. Shureiqi I, et al. Curr Opin Oncol. 1999 Sep;11(5):408-13. doi: 10.1097/00001622-199909000-00016. Curr Opin Oncol. 1999. PMID: 10505781 Review.

3

Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers.

Shureiqi I, Wojno KJ, Poore JA, Reddy RG, Moussalli MJ, Spindler SA, Greenson JK, Normolle D, Hasan AA, Lawrence TS, Brenner DE. Shureiqi I, et al. Carcinogenesis. 1999 Oct;20(10):1985-95. doi: 10.1093/carcin/20.10.1985. Carcinogenesis. 1999. PMID: 10506115

4

Chemoprevention: general perspective.

Shureiqi I, Reddy P, Brenner DE. Shureiqi I, et al. Crit Rev Oncol Hematol. 2000 Mar;33(3):157-67. doi: 10.1016/s1040-8428(99)00072-4. Crit Rev Oncol Hematol. 2000. PMID: 10789490 Review.

5

15-LOX-1: a novel molecular target of nonsteroidal anti-inflammatory drug-induced apoptosis in colorectal cancer cells.

Shureiqi I, Chen D, Lee JJ, Yang P, Newman RA, Brenner DE, Lotan R, Fischer SM, Lippman SM. Shureiqi I, et al. J Natl Cancer Inst. 2000 Jul 19;92(14):1136-42. doi: 10.1093/jnci/92.14.1136. J Natl Cancer Inst. 2000. PMID: 10904086

6

Colonic mucosal prostaglandin E2 and cyclooxygenase expression before and after low aspirin doses in subjects at high risk or at normal risk for colorectal cancer.

Krishnan K, Ruffin MT, Normolle D, Shureiqi I, Burney K, Bailey J, Peters-Golden M, Rock CL, Boland CR, Brenner DE. Krishnan K, et al. Among authors: shureiqi i. Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):447-53. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11352853 Clinical Trial.

7

Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer.

McGinn CJ, Zalupski MM, Shureiqi I, Robertson JM, Eckhauser FE, Smith DC, Brown D, Hejna G, Strawderman M, Normolle D, Lawrence TS. McGinn CJ, et al. Among authors: shureiqi i. J Clin Oncol. 2001 Nov 15;19(22):4202-8. doi: 10.1200/JCO.2001.19.22.4202. J Clin Oncol. 2001. PMID: 11709563 Clinical Trial.

8

Clinical and economic impact of multiple gated acquisition scan monitoring during anthracycline therapy.

Shureiqi I, Cantor SB, Lippman SM, Brenner DE, Chernew ME, Fendrick AM. Shureiqi I, et al. Br J Cancer. 2002 Jan 21;86(2):226-32. doi: 10.1038/sj.bjc.6600037. Br J Cancer. 2002. PMID: 11870511 Free PMC article.

9

Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression.

Shureiqi I, Xu X, Chen D, Lotan R, Morris JS, Fischer SM, Lippman SM. Shureiqi I, et al. Cancer Res. 2001 Jun 15;61(12):4879-84. Cancer Res. 2001. PMID: 11406566

10

Lipoxygenase modulation to reverse carcinogenesis.

Shureiqi I, Lippman SM. Shureiqi I, et al. Cancer Res. 2001 Sep 1;61(17):6307-12. Cancer Res. 2001. PMID: 11522616 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters